Gongwin Biopharm Co., Ltd.   Report issue

For profit Phase 2
Founded: Taipei Taiwan (2000)

Organization Overview

First Clinical Trial
2018
NCT03447951
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Gongwin Biopharm Co., Ltd.